AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31163975 — intervention group
Group type: EXPERIMENTAL
Intervention: Four or five syndemic factors
Number of subjects: 295
Study 31300264 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric vestibular stimulation (CVS) via a portable device, self-administered twice daily for 8 weeks.
Number of subjects: 33
Study 31300264 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (no specific details provided).
Number of subjects: 33
Study 28961838 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP administered every 14 days with CNS prophylaxis (IT methotrexate)
Number of subjects: 1080
Study 28961838 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP administered every 21 days with CNS prophylaxis (IT methotrexate)
Number of subjects: 1080
Study 28961838 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS prophylaxis (IT methotrexate)
Number of subjects: 1080
Study 28961838 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS-IPI high-risk group (4-6 risk factors)
Number of subjects: 1080
Study 24932945 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair testing for marijuana
Number of subjects: 360
Study 24932945 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair testing for cocaine
Number of subjects: 360
Study 24932945 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair testing for amphetamines
Number of subjects: 360
Study 24932945 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair testing for opioids
Number of subjects: 360
Study 24932945 — intervention group
Group type: COMPARATOR
Intervention: Self-reported drug use
Number of subjects: 360
Study 24349541 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-reported risk factors including body mass index, knee pain, previous knee replacement, and analgesia use for joint pain.
Number of subjects: 1462
Study 24349541 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-variable predictive model based on self-reported risk factors.
Number of subjects: 1462
Study 24349541 — intervention group
Group type: EXPERIMENTAL
Intervention: WOMAC weighted score for knee pain assessment.
Number of subjects: 1462
Study 20006198 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of metal stylet
Number of subjects: 80
Study 20006198 — intervention group
Group type: COMPARATOR
Intervention: No stylet
Number of subjects: 80
Study 20006198 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall assessment (both groups)
Number of subjects: 80
Study 18778385 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 326
Study 18778385 — intervention group
Group type: COMPARATOR
Intervention: Drug Information and Advice (Control)
Number of subjects: 326
Study 16914772 — intervention group
Group type: EXPERIMENTAL
Intervention: autologous fibrin tissue adhesive (auto‐FTA)
Number of subjects: 100
Study 16914772 — intervention group
Group type: COMPARATOR
Intervention: control group (standard treatment alone)
Number of subjects: 100
Study 12809330 — intervention group
Group type: EXPERIMENTAL
Intervention: Heptavalent conjugate vaccine
Number of subjects: 0
Study 12809330 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugate vaccination
Number of subjects: 0
Study 12809330 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugate vaccine
Number of subjects: 0
Study 12809330 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 10894286 — intervention group
Group type: EXPERIMENTAL
Intervention: famciclovir 500 mg twice a day
Number of subjects: 293
Study 10894286 — intervention group
Group type: COMPARATOR
Intervention: acyclovir 400 mg five times a day
Number of subjects: 293
Study 1537535 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrohydraulic water-bath lithotripter at 18 +/- 1 kV (Group A, n = 20)
Number of subjects: 86
Study 1537535 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrohydraulic water-cushion lithotripter at 19 +/- 2 kV (Group B, n = 25)
Number of subjects: 86
Study 1537535 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrohydraulic water-cushion lithotripter at 22 +/- 2 kV (Group C, n = 41)
Number of subjects: 86
Study 1537535 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Group A and Group B
Number of subjects: 86
Study 6505269 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of alpha 2 Interferon (20 X 10(6) I.U./m2 subcutaneously three times weekly for 3 months)
Number of subjects: 18
Study 6505269 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of alpha 2 Interferon (50 X 10(6) I.U./m2 intravenously daily for 5 consecutive days every 4 weeks)
Number of subjects: 18
Study 31374019 — intervention group
Group type: EXPERIMENTAL
Intervention: Rational-emotive language education (RELE)
Number of subjects: 68
Study 31374019 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 68
Study 29945650 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) with telephone support
Number of subjects: 90
Study 29945650 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy lifestyle intervention
Number of subjects: 90
Study 29945650 — intervention group
Group type: COMPARATOR
Intervention: Control group (active waiting list)
Number of subjects: 90
Study 29945650 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including those without depression)
Number of subjects: 90
Study 26756623 — intervention group
Group type: EXPERIMENTAL
Intervention: Object-related bilateral symmetrical training with mirror therapy (MT)
Number of subjects: 16
Study 26756623 — intervention group
Group type: COMPARATOR
Intervention: Control group observing the paretic upper limb directly
Number of subjects: 16
Study 25306688 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural blockade with local anesthetics and small doses of steroids
Number of subjects: 90
Study 22488227 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbopelvic joint manipulation (grade V)
Number of subjects: 48
Study 22488227 — intervention group
Group type: COMPARATOR
Intervention: Side‐lying lumbar midrange flexion and extension passive range of motion (grade II) for 1 minute
Number of subjects: 48
Study 22488227 — intervention group
Group type: COMPARATOR
Intervention: Prone extension on the elbows for 3 minutes
Number of subjects: 48
Study 22488227 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups pooled
Number of subjects: 48
Study 20569758 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 2835
Study 20569758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2835
Study 18052566 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 25-50 mg/day
Number of subjects: 332
Study 18052566 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine 75-150 mg/day
Number of subjects: 332
Study 18052566 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine
Number of subjects: 332
Study 18052566 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine
Number of subjects: 332
Study 15657688 — intervention group
Group type: EXPERIMENTAL
Intervention: Spouse dysfunctional problem-solving
Number of subjects: 171
Study 15657688 — intervention group
Group type: EXPERIMENTAL
Intervention: Spouse distress
Number of subjects: 171
Study 15657688 — intervention group
Group type: EXPERIMENTAL
Intervention: Spouse constructive problem-solving
Number of subjects: 171
Study 12399273 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mmol arginine/kg lean body mass
Number of subjects: 9
Study 12399273 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mmol arginine/kg lean body mass + 25 g glucose
Number of subjects: 9
Study 12399273 — intervention group
Group type: COMPARATOR
Intervention: 25 g glucose alone
Number of subjects: 9
Study 12399273 — intervention group
Group type: COMPARATOR
Intervention: Water only
Number of subjects: 9
Study 10455343 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ selected grafts using Isolex 300 device
Number of subjects: 26
Study 10455343 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ selected grafts using Isolex 300i device
Number of subjects: 26
Study 10455343 — intervention group
Group type: COMPARATOR
Intervention: Control group (unmanipulated PBPC)
Number of subjects: 26
Study 10455343 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall purging efficacy
Number of subjects: 26
Study 10455343 — intervention group
Group type: EXPERIMENTAL
Intervention: Serological parameters at 12 months post-transplant
Number of subjects: 26
Study 10455343 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient monoclonal or oligoclonal gammopathies
Number of subjects: 26
Study 8949760 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutron therapy
Number of subjects: 119
Study 8949760 — intervention group
Group type: COMPARATOR
Intervention: Photon therapy
Number of subjects: 119
Study 1924653 — intervention group
Group type: EXPERIMENTAL
Intervention: Type A counseling
Number of subjects: 0
Study 1924653 — intervention group
Group type: COMPARATOR
Intervention: Cardiac control group
Number of subjects: 0
Study 6805791 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraclean-air operating rooms
Number of subjects: 8000
Study 6805791 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation operating rooms
Number of subjects: 8000
Study 6805791 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraclean-air operating rooms with whole-body exhaust-ventilated suits
Number of subjects: 8000
Study 6805791 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 8000
Study 6805791 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 8000
Study 29752776 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraglottic airway (SGA) management in 72.7% of cases (n = 152)
Number of subjects: 220
Study 29752776 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation (ETI)
Number of subjects: 220
Study 28412747 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenomethionine (SEMET)
Number of subjects: 29
Study 28412747 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl selenocysteine (MSC)
Number of subjects: 29
Study 27355279 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender aroma
Number of subjects: 92
Study 27355279 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive prime (regardless of aroma type)
Number of subjects: 92
Study 24444781 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 12515
Study 24444781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12515
Study 24444781 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ASA
Number of subjects: 12515
Study 24444781 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose ASA
Number of subjects: 12515
Study 24444781 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ASA
Number of subjects: 12515
Study 22531418 — intervention group
Group type: EXPERIMENTAL
Intervention: γ-secretase inhibitor semagacestat (100 mg)
Number of subjects: 20
Study 22531418 — intervention group
Group type: EXPERIMENTAL
Intervention: γ-secretase inhibitor semagacestat (140 mg)
Number of subjects: 20
Study 22531418 — intervention group
Group type: EXPERIMENTAL
Intervention: γ-secretase inhibitor semagacestat (280 mg)
Number of subjects: 20
Study 22531418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 20805115 — intervention group
Group type: EXPERIMENTAL
Intervention: E5555 (50 mg)
Number of subjects: 504
Study 20805115 — intervention group
Group type: EXPERIMENTAL
Intervention: E5555 (100 mg)
Number of subjects: 504
Study 20805115 — intervention group
Group type: EXPERIMENTAL
Intervention: E5555 (200 mg)
Number of subjects: 504
Study 20805115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 504
Study 20805115 — intervention group
Group type: EXPERIMENTAL
Intervention: E5555 (combined)
Number of subjects: 504
Study 17683649 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 0
Study 15177806 — intervention group
Group type: EXPERIMENTAL
Intervention: Task switching between auditory and visual modalities
Number of subjects: 0
Study 11881864 — intervention group
Group type: EXPERIMENTAL
Intervention: β-adrenergic antagonists (β‐AAs)
Number of subjects: 0
Study 11881864 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute administration of β‐AAs
Number of subjects: 0
Study 9792124 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional tooth-cleaning and dental health education programme (test)
Number of subjects: 404
Study 9792124 — intervention group
Group type: COMPARATOR
Intervention: Standard preventive programme (control) comprising selective fissure sealing and application of topical fluorides
Number of subjects: 404
Study 9792124 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (test and control)
Number of subjects: 404
Study 9792124 — intervention group
Group type: COMPARATOR
Intervention: Standard preventive programme (control)
Number of subjects: 404
Study 7715038 — intervention group
Group type: EXPERIMENTAL
Intervention: Active compression-decompression (ACD) CPR
Number of subjects: 860
Study 7715038 — intervention group
Group type: COMPARATOR
Intervention: Standard manual CPR
Number of subjects: 860
Study 1939686 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational course in child maltreatment
Number of subjects: 50
Study 6102940 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (0.5‐3.0 mg)
Number of subjects: 86
Study 6102940 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (5‐60 mg)
Number of subjects: 86
Study 6102940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 31142369 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard PEEP (6-8 cm H2O)
Number of subjects: 208
Study 31142369 — intervention group
Group type: COMPARATOR
Intervention: Low PEEP (≤2 cm H2O)
Number of subjects: 208
Study 29061359 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate pulpotomy
Number of subjects: 54
Study 29061359 — intervention group
Group type: COMPARATOR
Intervention: Root canal treatment
Number of subjects: 54
Study 25534724 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of LFF571 four times daily for 10 days
Number of subjects: 0
Study 25534724 — intervention group
Group type: COMPARATOR
Intervention: 125 mg of vancomycin four times daily for 10 days
Number of subjects: 0
Study 23962593 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed reduction between days 1-5 after injury
Number of subjects: 24
Study 23962593 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed reduction between days 6-10 after injury
Number of subjects: 24
Study 23962593 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall closed reduction treatment
Number of subjects: 24
Study 21258836 — intervention group
Group type: EXPERIMENTAL
Intervention: Goshajinkigan (GJG) 7.5 g/day during mFOLFOX6 therapy
Number of subjects: 45
Study 21258836 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GJG)
Number of subjects: 45
Study 19038483 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM-based self-help intervention
Number of subjects: 2471
Study 19038483 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 2471
Study 17766506 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Steps
Number of subjects: 5565
Study 14985685 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA group (n=20) took active foods containing fish oil (3.6 g DHA/week) for 2 months
Number of subjects: 40
Study 14985685 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=20) took indistinguishable control foods without fish oil
Number of subjects: 40
Study 11767271 — intervention group
Group type: EXPERIMENTAL
Intervention: BASICS (Brief Alcohol Screening and Intervention for College Students)
Number of subjects: 99
Study 11767271 — intervention group
Group type: COMPARATOR
Intervention: Educational intervention
Number of subjects: 99
Study 11767271 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 99
Study 9599737 — intervention group
Group type: COMPARATOR
Intervention: Enuretic group (treatment)
Number of subjects: 0
Study 9599737 — intervention group
Group type: COMPARATOR
Intervention: Group A (low UOP, large NUV)
Number of subjects: 0
Study 9599737 — intervention group
Group type: EXPERIMENTAL
Intervention: Before treatment
Number of subjects: 0
Study 9599737 — intervention group
Group type: EXPERIMENTAL
Intervention: After treatment
Number of subjects: 0
Study 9599737 — intervention group
Group type: COMPARATOR
Intervention: Group D (normal UOP, small NUV)
Number of subjects: 0
Study 7977541 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilapan osmotic dilator
Number of subjects: 1001
Study 7977541 — intervention group
Group type: COMPARATOR
Intervention: Laminaria japonicum
Number of subjects: 1001
Study 2732164 — intervention group
Group type: COMPARATOR
Intervention: 12% O2 for 20 min
Number of subjects: 9
Study 2732164 — intervention group
Group type: COMPARATOR
Intervention: 10% O2 for 20 min
Number of subjects: 9
Study 2732164 — intervention group
Group type: COMPARATOR
Intervention: 8% O2 for 10 min
Number of subjects: 9
Study 143889 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced abortion with concurrent tubal ligation (Group 1)
Number of subjects: 2421
Study 143889 — intervention group
Group type: COMPARATOR
Intervention: Induced abortion only (Group 2)
Number of subjects: 2421
Study 143889 — intervention group
Group type: COMPARATOR
Intervention: Interval culdoscopic ligation
Number of subjects: 2421
Study 30817436 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 55
Study 30817436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 28903775 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin
Number of subjects: 0
Study 28903775 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hydroxy saxagliptin
Number of subjects: 0
Study 28903775 — intervention group
Group type: COMPARATOR
Intervention: Animal studies
Number of subjects: 0
Study 26002049 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg/day
Number of subjects: 102
Study 23780782 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep (12 hours with sleep)
Number of subjects: 60
Study 23780782 — intervention group
Group type: COMPARATOR
Intervention: Wakefulness (12 hours without sleep)
Number of subjects: 60
Study 21373802 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES)
Number of subjects: 46
Study 21373802 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 46
Study 21373802 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES) in children with normal upper GI motility (NUGM)
Number of subjects: 46
Study 21373802 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES) in children with upper gastrointestinal dysmotility (UGD)
Number of subjects: 46
Study 19631046 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral weight control program (12-week, 12 sessions of 1 hour each)
Number of subjects: 216
Study 19631046 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral weight control program
Number of subjects: 216
Study 17091118 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based STI self-collection and testing
Number of subjects: 818
Study 17091118 — intervention group
Group type: COMPARATOR
Intervention: Clinic appointment
Number of subjects: 818
Study 15056136 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-mm spot size
Number of subjects: 0
Study 15056136 — intervention group
Group type: COMPARATOR
Intervention: 12-mm spot size
Number of subjects: 0
Study 11313839 — intervention group
Group type: EXPERIMENTAL
Intervention: clomipramine
Number of subjects: 31
Study 11313839 — intervention group
Group type: EXPERIMENTAL
Intervention: sertraline
Number of subjects: 31
Study 11313839 — intervention group
Group type: EXPERIMENTAL
Intervention: paroxetine
Number of subjects: 31
Study 11313839 — intervention group
Group type: EXPERIMENTAL
Intervention: sildenafil
Number of subjects: 31
Study 11313839 — intervention group
Group type: EXPERIMENTAL
Intervention: pause-squeeze technique
Number of subjects: 31
Study 9389847 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloid priming with Ringer's lactate
Number of subjects: 26
Study 9389847 — intervention group
Group type: EXPERIMENTAL
Intervention: Human albumin priming solution
Number of subjects: 26
Study 9389847 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass surgery (control group)
Number of subjects: 26
Study 7911562 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 Hz tetanic stimulation
Number of subjects: 25
Study 7911562 — intervention group
Group type: COMPARATOR
Intervention: 50 Hz tetanic stimulation
Number of subjects: 25
Study 3316303 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide (5 mg)
Number of subjects: 17
Study 3316303 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Bendroflumethiazide + Nifedipine)
Number of subjects: 17
Study 31810865 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker-guided recommendation on antibiotics (n=104)
Number of subjects: 210
Study 31810865 — intervention group
Group type: COMPARATOR
Intervention: Routine use of antibiotics (n=106)
Number of subjects: 210
Study 29702672 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDSVAX®B/E
Number of subjects: 0
Study 29702672 — intervention group
Group type: EXPERIMENTAL
Intervention: ALVAC-HIV/AIDSVAX®B/E
Number of subjects: 0
Study 29702672 — intervention group
Group type: COMPARATOR
Intervention: ALVAC-HIV
Number of subjects: 0
Study 29702672 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDSVAX®B/E and ALVAC-HIV/AIDSVAX®B/E
Number of subjects: 0
Study 27367045 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity neuromuscular training (NMT) program for 12 weeks
Number of subjects: 725
Study 25676082 — intervention group
Group type: EXPERIMENTAL
Intervention: Supporting Father Involvement intervention
Number of subjects: 0
Study 23203337 — intervention group
Group type: EXPERIMENTAL
Intervention: BioCleanse-sterilized allografts
Number of subjects: 67
Study 23203337 — intervention group
Group type: COMPARATOR
Intervention: aseptic BTB allografts
Number of subjects: 67
Study 23203337 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 67
Study 20511693 — intervention group
Group type: EXPERIMENTAL
Intervention: Early weight bearing after surgical repair of ATR
Number of subjects: 73